EG vs MGRX · P/E 17, rev $8.03B vs rev $456.0K
Everest Group Ltd (EG) versus Mangoceuticals, Inc. Common Stock (MGRX) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Latest reported EG revenue for 2026-06-30 was $8.03B. Net income was $1.21B. Revenue was up 97.4% from 2026-03-31 to 2026-06-30. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
EG currently screens at market cap $14.52B and trailing P/E 17.2. MGRX currently screens at market cap $16.3M.
Not investment advice. Open the EG and MGRX stock pages for the full models.
Not investment advice.